TDC
75
4
ABT
57
-5
NWS
62
-2
NI
75
2
WMT
74
2
JWN
40
-2
TAP
58
-2
EFX
32
2
EQIX
60
-2
CINF
47
2
ZTS
47
2
USB
50
2
BEN
45
3
AVGO
20
-5
HP
38
-2
JPM
63
-4
MAS
51
4
LB
34
8
IBM
54
4
MDLZ
34
2
TDC
75
4
ABT
57
-5
NWS
62
-2
NI
75
2
WMT
74
2
JWN
40
-2
TAP
58
-2
EFX
32
2
EQIX
60
-2
CINF
47
2
ZTS
47
2
USB
50
2
BEN
45
3
AVGO
20
-5
HP
38
-2
JPM
63
-4
MAS
51
4
LB
34
8
IBM
54
4
MDLZ
34
2
Financhill
Back

Corcept Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
78

CORT
Corcept Therapeutics

Last Price:
56.09
Seasonality Move:
2.29%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
248.79
Seasonality Move:
10.85%
Buy
78
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $56.09. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $56.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $248.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.41 Buy
Relative Strength Index (14 RSI): 62.02 Buy
Chaikin Money Flow: 911392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.68 - 55.6) Buy
Bollinger Bands (100): (32.78 - 48.56) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.64 Sell
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 997085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (254.01 - 292.55) Sell
Bollinger Bands (100): (248.69 - 281.73) Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.37 Buy
20-day SMA: 52.39 Buy
50-day SMA: 47.38 Buy
200-day SMA: 33.34 Buy
8-day EMA: 54.58 Buy
20-day EMA: 52.72 Buy
50-day EMA: 47.93 Buy
200-day EMA: 36.85 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 252.75 Sell
20-day SMA: 267.61 Sell
50-day SMA: 273.13 Sell
200-day SMA: 210.87 Buy
8-day EMA: 250.09 Sell
20-day EMA: 262.36 Sell
50-day EMA: 266.92 Sell
200-day EMA: 230.73 Buy

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):